Addus HomeCare Corporation (ADUS)
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
Addus HomeCare Corporation (ADUS) Presents at UBS Global Healthcare Conference 2025 Transcript
Addus HomeCare Corporation ( ADUS ) UBS Global Healthcare Conference 2025 November 12, 2025 10:15 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division I think we'll get going with our next presenter here, Addus Healthcare -- or Home care, rather, very pleased to have them participating in our conference this year.
Addus HomeCare Corporation (ADUS) Q3 2025 Earnings Call Transcript
Addus HomeCare Corporation ( ADUS ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Dru Anderson - Corporate Communications, Inc. Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Jared Haase - William Blair & Company L.L.C.
Addus HomeCare: Decent Print, Weak Economics, Stay On Hold
Q2 revenue was $349.4m, up 21.8% YoY, with adjusted EBITDA of $43.9m and operating cash flow of $22.5m. The business continues to acquire growth and has committed $1.20 in M&A per $1 of new sales over the last 3 years. Returns on capital remain low at ~8–9%, with fair value estimated at $80–$90/share.
Addus HomeCare Corporation (ADUS) Q2 2025 Earnings Call Transcript
Addus HomeCare Corporation (NASDAQ:ADUS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Brian W. Poff - CFO, Executive VP, Secretary & Treasurer R.
Addus HomeCare (ADUS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.35 per share a year ago.
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?
Addus HomeCare Corporation (ADUS) Q1 2025 Earnings Call Transcript
Addus HomeCare Corporation (NASDAQ:ADUS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Tao Qiu - Macquarie Jared Haase - William Blair Matthew Gillmor - KeyBanc Meghan Holtz - Jefferies Constantine Davides - Citizens Bank Ryan Langston - TD Cowen John Ransom - Raymond James Operator Good day, and welcome to the Addus HomeCare First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Addus HomeCare (ADUS) Beats Q1 Earnings Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.21 per share a year ago.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
